Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CCR5 | P51681 | 5/20 | 0.42 |
| ▸ | MCL1 | Q07820 | 5/20 | 0.41 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.40 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.40 |
| ▸ | NR1H2 | P55055 | 1/20 | 0.40 |
| ▸ | NR1H3 | Q13133 | 1/20 | 0.40 |
| ▸ | KLK7 | P49862 | 1/20 | 0.40 |
| ▸ | ATM | Q13315 | 1/20 | 0.39 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.38 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.38 |
| ▸ | MMP1 | P03956 | 1/20 | 0.37 |
| ▸ | MMP2 | P08253 | 1/20 | 0.37 |
| ▸ | MMP9 | P14780 | 1/20 | 0.37 |
| ▸ | MMP8 | P22894 | 1/20 | 0.37 |
| ▸ | MMP13 | P45452 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL23668279 | 0.93 | CCR5 (0.43) | CCR5MCL1TDP1MAPK1KLK7 | |
| SCHEMBL28574162 | 0.92 | NR1H2 (0.44) | CCR5MCL1NR1H2NR1H3KLK7 | |
| SCHEMBL28577303 | 0.89 | MMP2 (0.46) | CCR5TDP1MAPK1ATMALDH1A1 | |
| SCHEMBL30695875 | 0.88 | MAPK1 (0.41) | CCR5TDP1MAPK1ATMALDH1A1 | |
| SCHEMBL24142140 | 0.86 | MAPK1 (0.43) | CCR5TDP1MAPK1ATMALDH1A1 | |
| SCHEMBL24142105 | 0.86 | MAPK1 (0.43) | CCR5TDP1MAPK1ATMALDH1A1 | |
| SCHEMBL24142137 | 0.85 | MMP2 (0.46) | CCR5TDP1MAPK1ATMALDH1A1 | |
| SCHEMBL23668282 | 0.84 | NR1H2 (0.42) | CCR5MCL1NR1H2NR1H3KLK7 | |
| SCHEMBL23668284 | 0.81 | MAPK1 (0.43) | CCR5TDP1MAPK1ATMALDH1A1 | |
| SCHEMBL15347117 | 0.81 | MEN1 (0.43) | MCL1KLK7ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3854786-B1 | METHOD FOR PRODUCING AMINO ACID DERIVATIVES | UBE CORP (JP) | 2026-02-18 | — | — | EP | disclosed |
| US-12281074-B2 | Method for producing amino acid derivatives | UBE CORPORATION (JP) | 2025-04-22 | — | — | US | disclosed |
| CN-119707784-A | Process for preparing amino acid derivatives | 株式会社API | 2025-03-28 | — | — | CN | disclosed |
| US-12202800-B2 | Method for producing amino acid derivatives | API CORPORATION (JP) | 2025-01-21 | — | — | US | disclosed |
| CN-112930338-B | Process for preparing amino acid derivatives | 株式会社API | 2024-12-24 | — | — | CN | disclosed |
| US-20240150292-A1 | METHOD FOR PRODUCING AMINO ACID DERIVATIVES | API CORPORATION (JP) | 2024-05-09 | — | — | US | disclosed |
| US-11897844-B2 | Method for producing amino acid derivatives | API CORPORATION (JP) | 2024-02-13 | — | — | US | disclosed |
| US-20240002340-A1 | METHOD FOR PRODUCING AMINO ACID DERIVATIVES | API CORPORATION (JP) | 2024-01-04 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240150292-A1 | METHOD FOR PRODUCING AMINO ACID DERIVATIVES | PTGS2, PTGES, PTGS1 | CCR5 3732/4885MCL1 3260/4885TDP1 3851/4885 |
| US-12202800-B2 | Method for producing amino acid derivatives | GLO1, BCAT2, BCAT1 | CCR5 4626/4885MCL1 1451/4885TDP1 4509/4885 |
| US-20240002340-A1 | METHOD FOR PRODUCING AMINO ACID DERIVATIVES | GLO1, BCAT2, BCAT1 | CCR5 4626/4885MCL1 1451/4885TDP1 4509/4885 |
| US-11897844-B2 | Method for producing amino acid derivatives | PTGS2, PTGES, PTGES2 | CCR5 3724/4885MCL1 3496/4885TDP1 3836/4885 |
| US-12281074-B2 | Method for producing amino acid derivatives | PTGS2, PTGES, PTGES2 | CCR5 3724/4885MCL1 3496/4885TDP1 3836/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.